Status:
UNKNOWN
Evaluation of the Public Health Impact of Seasonal Intermittent Preventive Treatment (IPT) in Children in Senegal
Lead Sponsor:
London School of Hygiene and Tropical Medicine
Collaborating Sponsors:
Senegal: Ministere de la Sante
Institut de Recherche pour le Developpement
Conditions:
Malaria
Eligibility:
All Genders
3-119 years
Phase:
PHASE4
Brief Summary
In areas of seasonal malaria transmission the burden of severe disease and mortality due to malaria is mainly among children under 5 years of age. Intermittent preventive treatment (IPT) with antimala...
Eligibility Criteria
Inclusion
- Age 3-119 months at time of first administration of IPT in September
- Consent of mother or carer and the local community
Exclusion
- History of allergy to SP or AQ
- Age \< 3 months or \>119 months at time of first administration of IPT in September
- From 2009, the age for inclusion has been changed from 3-59 months to 3 months to 10 years of age.
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2012
Estimated Enrollment :
100000 Patients enrolled
Trial Details
Trial ID
NCT00712374
Start Date
September 1 2008
End Date
July 1 2012
Last Update
September 22 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.